Private company
Ligachem Biosciences Inc.
Logo: ligachembio.com3
Ligachem Biosciences Inc. is a South Korean company.1
주식회사 리가켐바이오사이언스(영어: LigaChem Biosciences)는 대한민국의 바이오 기업이다.2 From the Korean Wikipedia, CC BY-SA 4.0
Last updated Oct 21, 2026.
Overview
- Websitewww.ligachembio.com
- Listed onKOSDAQ1
Calendar
Drug trials and FDA: coming up
- Jan 2027Phase 1/2 trial readout expected Phase 1/2 trial of LCB84 and Anti-PD-1 monoclonal antibody in Advanced Solid Tumors: primary completion expected Jan 2027 (ClinicalTrials.gov NCT05941507).4
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). Trials from ClinicalTrials.gov, as the sponsor registered them (expected dates are the sponsor's own and often move); approvals and advisory committee meetings from the FDA. The FDA does not publish its decision (PDUFA) dates. The full markets calendar
Links
- Websitewww.ligachembio.com1
- WikidataQ131188058
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3Company websiteLigachem Biosciences Inc. logo
- 4